Electrode Configurations for Reducing Invasiveness and/or Enhancing Neural Stimulation Efficacy, and Associated Methods
Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods, are disclosed. A method in accordance with one embodiment of the invention for treating a brain disorder includes identifying a target neural structure within a patient's skull and implanting an electrode device within the patient's skull so that an axis that is generally normal to the skull proximate to the electrode device and that passes through at least one electrical contact of the electrode device is offset from the target neural structure. The method further includes stimulating the target neural structure by applying an electrical signal to the at least one electrical contact. In particular embodiments, the electrode device can be positioned between, along, across, or adjacent to a fissure, recess, groove, and/or vascular structure of the patient's brain.
1 - 81 . (canceled)
82 . A method for treating a patient, comprising:
implanting at least one electrode beneath the patient's skull, proximate to a target neural population of the patient's brain; and
affecting a functioning of the target neural population by engaging the patient in a treatment regimen that includes:
directing an electrical signal from the at least one electrode to the target neural population; and
engaging the patient in a biofeedback task.
83 . The method of claim 82 , further comprising identifying the patient as suffering from depression, and wherein implanting the at least one electrode includes implanting the at least one electrode at a location selected based at least in part on identifying the patient as suffering from depression, and wherein directing an electrical signal includes directing a monopolar signal, and wherein affecting the functioning of the target neural population includes treating the patient's depression.
84 . The method of claim 82 , further comprising identifying the patient as suffering from depression, and wherein affecting the functioning of the target neural population includes treating the patient's depression.
85 . The method of claim 82 , further comprising identifying the patient as suffering from an auditory dysfunction, and wherein affecting the functioning of the target neural population includes treating the patient's auditory dysfunction.
86 . The method of claim 85 wherein identifying the patient as suffering from an auditory dysfunction includes identifying the patient as suffering from tinnitus.
87 . The method of claim 85 wherein identifying the patient as suffering from an auditory dysfunction includes identifying the patient as suffering from auditory hallucinations.
88 . The method of claim 82 , further comprising identifying the patient as suffering from a neuropsychiatric disorder, and wherein affecting the functioning of the target neural population includes treating the patient's neuropsychiatric disorder.
89 . The method of claim 82 , further comprising identifying the patient as suffering from anxiety, and wherein affecting the functioning of the target neural population includes treating the patient's anxiety.
90 . The method of claim 82 , further comprising identifying the patient as suffering from a cognitive disorder, and wherein affecting the functioning of the target neural population includes treating the patient's cognitive disorder.
91 . The method of claim 82 , further comprising identifying the patient as suffering from a learning disorder, and wherein affecting the functioning of the target neural population includes treating the patient's learning disorder.
92 . The method of claim 82 , further comprising identifying the patient as suffering from post-traumatic stress disorder, and wherein affecting the functioning of the target neural population includes treating the patient's post-traumatic stress disorder.
93 . The method of claim 82 , further comprising identifying the patient as suffering from obsessive/compulsive disorder, and wherein affecting the functioning of the target neural population includes treating the patient's obsessive/compulsive disorder.
94 . The method of claim 82 , further comprising identifying the patient as suffering from a sleep disorder, and wherein affecting the functioning of the target neural population includes treating the patient's sleep disorder.
95 . The method of claim 82 , further comprising identifying the patient as suffering from an addiction, and wherein affecting the functioning of the target neural population includes treating the patient's addiction.
96 . The method of claim 82 , further comprising identifying the patient as suffering from pain, and wherein affecting the functioning of the target neural population includes effectuating a reduction in the patient's pain.